Examples of the disclosure include a method to aid user monitoring of a disordered breathing treatment, comprising providing, by an application running on a user computing device, a patient-selection screen of a graphical user interface (GUI) on a display device of the user computing device; receiving, via an input field of the patient-selection screen, an input from the user indicative of a selected patient; communicating between the user computing device and a treatment system implanted in the selected patient, responsive to receipt of the input indicative of the selected patient, to transfer patient data from the treatment system to the user computing device; and providing, by the application, a diagnostic reporting and monitoring screen including one or more graphical illustrations indicative of sleep position data for the selected patient in combination with one or more graphical illustrations of other data for the selected patient on the GUI.

Technologies and implementations for determining a respiration rate of a person from heart rate monitoring signal is disclosed.

The present disclosure provides biosymbiotic systems and devices for continuous monitoring of electrophysiological biosignals. The systems and devices described herein include carbon-doped filament deposition modeling (FDM) printed dry electrodes that overcome impedance degradation by seamless integration into textile and wearable biosymbiotic platforms, allowing for high fidelity operation over indefinite timescales. The systems and devices also include at-distance wirelessly powered wearable electronics. The systems and devices described herein can be used to monitor ECG/EIP during work, activity, and sleep and BioZ recordings documenting gains in forearm training over weeks.

Systems and methods are provided for delivering neurostimulation therapies to patients. Stimulation from an implantable medical device (IMD) may be suspended in response to detecting a patient discomfort event, such as a cough, throat irritation, or voice alteration. The suspension period may be based on at least one of a severity level of the patient discomfort event and a patient physical state, such as being asleep or lying down. Detection of a patient discomfort event may be calibrated.

A system for ventilation of a being, comprising at least one ventilator and at least one EIT measuring device, the ventilator comprising at least one controllable respiratory gas source and a programmable control unit for controlling the respiratory gas source and the EIT measuring device comprising at least one sensor apparatus for measuring impedance values of at least one lung of the being and at least one calculation and evaluation unit, and the system assigning the impedance values measured by way of the at least one sensor apparatus to pixels n, and the control unit being configured as specified in the claims.

Devices, systems and methods of neurostimulation for treating obstructive sleep apnea. The system is adapted to send an electrical signal from an implanted neurostimulator through a stimulation lead to a patient's nerve at an appropriate phase of the respiratory cycle based on input from a respiration sensing lead. External components are adapted for wireless communication with the neurostimulator. The neurostimulator is adapted to deliver therapeutic stimulation based on inputs.

A system and method for automatically implementing a therapy for treating sleep disordered breathing.

A system for ventilation of a being, comprising at least one ventilator and at least one EIT measuring device, the ventilator comprising at least one controllable respiratory gas source and a programmable control unit for controlling the respiratory gas source and the EIT measuring device comprising at least one sensor apparatus for measuring impedance values of at least one lung of the being and at least one calculation and evaluation unit, and the system assigning the impedance values measured by way of the at least one sensor apparatus to pixels n, and the control unit being configured as specified in the claims.

Technologies and implementations for determining a respiration rate of a person from heart rate monitoring signal is disclosed.

A medical device for measuring an impedance of a patient or mammal when a current is applied by electrodes. The medical device includes an output transmits a drive signal to a set of drive electrodes coupled to a patient and an input receives a sense signal generated by a set of sensing electrodes coupled to the patient. A processor determines the impedance of the patient based on the drive signal transmitted to the set of drive electrodes and the sense signal received by the set of sensing electrodes. A user interface displays the determined impedance.